Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

"I Feel Good": The Many Flaws of the Wellness Movement.

The American journal of bioethics : AJOB·2026
Same author

Challenges and Errors in Genetic Testing: The Sixth Case Series.

Cancer journal (Sudbury, Mass.)·2026
Same author

The Epstein scandal is a wake-up call - new rules are needed on links with rich donors.

Nature·2026
Same author

The Executive Order on "Crime and Disorder": An Affront to Policy, Law, and Ethics.

Psychiatric services (Washington, D.C.)·2026
Same author

The United States platelet shortage: Whole blood derived platelets or paying donors.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Is concurrent gestational surrogacy an ethical practice?

Fertility and sterility·2026

Related Experiment Video

Updated: Jul 2, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Direct to confusion: lessons learned from marketing BRCA testing.

Ellen Matloff1, Arthur Caplan

  • 1Yale Cancer Center, 55 Church Street, Suite 402, New Haven, CT 06520, USA. ellen.matloff@yale.edu

The American Journal of Bioethics : AJOB
|August 30, 2008
PubMed
Summary

Myriad Genetics

Area of Science:

  • Genetics and Genomics
  • Bioethics
  • Healthcare Policy

Background:

  • Myriad Genetics holds a patent for BRCA1 and BRCA2 gene testing, creating a monopoly.
  • This patent impacts access to critical hereditary cancer genetic testing.
  • Direct-to-Consumer (DTC) marketing of genetic tests raises ethical concerns.

Purpose of the Study:

  • To review the ethics of Myriad Genetics' patent and monopoly on BRCA1/BRCA2 testing.
  • To analyze the impact of this situation on patient care and physician liability.
  • To examine the implications for future DTC genetic testing campaigns.

Main Methods:

  • Review of patent law and ethical guidelines.
  • Analysis of healthcare access and patient outcomes data.

More Related Videos

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

Related Experiment Videos

Last Updated: Jul 2, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1
08:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors
09:22

Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

Published on: February 28, 2021

  • Examination of marketing strategies and physician responsibilities.

    • Main Results:

    • The patent creates a monopoly, potentially limiting patient access and increasing costs.
    • DTC marketing raises concerns about informed consent and appropriate test utilization.
    • Physician liability may increase due to complex genetic information and DTC advertising.

    Conclusions:

    • The Myriad Genetics patent situation highlights ethical challenges in genetic testing monopolies.
    • Patient access, informed consent, and physician roles require careful consideration.
    • Future DTC genetic testing requires robust ethical frameworks and regulatory oversight.